Jin Han Kang
Overview
Explore the profile of Jin Han Kang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
787
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahn B, Kang K, Kim Y, Cho Y, Jo S, Yoo J, et al.
Vaccines (Basel)
. 2025 Jan;
12(12.
PMID: 39772033
Background: Varicella can lead to severe complications in immunocompromised children, including those undergoing hematopoietic stem cell transplantation (HSCT) or chemotherapy. Preventing primary varicella zoster virus (VZV) infection is crucial in...
2.
Hur M, Kang K, Kim Y, Cho Y, Lee J, Chung N, et al.
Vaccines (Basel)
. 2024 Nov;
12(11).
PMID: 39591127
Pediatric patients who have undergone hematopoietic stem cell transplantation (HSCT) or chemotherapy are at increased risk for severe influenza complications, necessitating annual vaccination. This study evaluated the immunogenicity and antibody...
3.
Lee J, Bae K, Rhim J, Lee S, Jeong D, Kang J
Children (Basel)
. 2024 Jul;
11(7).
PMID: 39062205
Macrophage activation syndrome (MAS) is potentially fatal; so, early diagnosis and timely treatment are essential. However, detecting MAS is sometimes challenging because its principal features can be observed in other...
4.
Ji H, Kang K, Kang H, Choi U, Lee S, Kang J
Medicine (Baltimore)
. 2024 Jan;
103(3):e36931.
PMID: 38241578
Universal varicella vaccination (UVV), as a single dose to children aged 12 to 15 months, was introduced in Korea in 2005. A seroprevalence study is required to upgrade this UVV...
5.
Kang H, Kang K, Kim Y, Kang J, Lee S
J Med Virol
. 2024 Jan;
96(1):e29410.
PMID: 38235847
No abstract available.
6.
Kang H, Kang K, Kim Y, Kang J, Lee S
J Med Virol
. 2023 Sep;
95(9):e29108.
PMID: 37715715
Live varicella vaccines are known to provide robust immunity against varicella zoster virus (VZV) infections. However, problems with viral attenuation have led to pathogenic VZV vaccine strains causing varicella-like rash...
7.
Kim Y, Hong M, Kang H, Yum S, Youn Y, Lee D, et al.
Antimicrob Resist Infect Control
. 2023 Jul;
12(1):68.
PMID: 37443079
Introduction: This study aimed to assess the role of adenosine triphosphate (ATP) bioluminescence level monitoring for identifying reservoirs of the outbreak pathogen during two consecutive outbreaks caused by Enterococcus faecium...
8.
Bae E, Kim Y, Kang H, Jeong D, Kang J
Antibiotics (Basel)
. 2022 Sep;
11(9).
PMID: 36140012
In the last few decades, macrolide-resistant Mycoplasma pneumoniae (MRMP) has been increasing in proportion. This study aimed to evaluate the treatment outcomes of children with lobar or segmental MP pneumonia...
9.
Kang K, Kim Y, Ahn M, Kang H, Kim S, Lee J, et al.
Bone Marrow Transplant
. 2022 Aug;
57(10):1620-1622.
PMID: 35915154
No abstract available.
10.
Kim S, Han S, Kang J
Int J Immunopathol Pharmacol
. 2022 May;
36:3946320221095015.
PMID: 35575295
Introduction: Although prolonged fever in patients with neutropenic fever (NF) during empirical antibiotic therapy could be caused by dysregulated immune responses, its association with cytokine concentrations has rarely been investigated....